Annual Accounts Receivable
$1.11 M
+$938.00 K+542.20%
December 31, 2023
Summary
- As of February 7, 2025, ALT annual accounts receivable is $1.11 million, with the most recent change of +$938.00 thousand (+542.20%) on December 31, 2023.
- During the last 3 years, ALT annual accounts receivable has fallen by -$3.50 million (-75.90%).
- ALT annual accounts receivable is now -87.47% below its all-time high of $8.87 million, reached on December 31, 2009.
Performance
ALT Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$428.00 K
+$4000.00+0.94%
September 30, 2024
Summary
- As of February 7, 2025, ALT quarterly accounts receivable is $428.00 thousand, with the most recent change of +$4000.00 (+0.94%) on September 30, 2024.
- Over the past year, ALT quarterly accounts receivable has dropped by -$683.00 thousand (-61.48%).
- ALT quarterly accounts receivable is now -96.08% below its all-time high of $10.91 million, reached on September 30, 2008.
Performance
ALT Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ALT Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +542.2% | -61.5% |
| 3 y3 years | -75.9% | -72.8% |
| 5 y5 years | -67.9% | -57.7% |
ALT Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +542.2% | -61.5% | +214.7% |
| 5 y | 5-year | -75.9% | +542.2% | -91.1% | +214.7% |
| alltime | all time | -87.5% | +903.6% | -96.1% | -100.0% |
Altimmune Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $428.00 K(+0.9%) |
| Jun 2024 | - | $424.00 K(+38.1%) |
| Mar 2024 | - | $307.00 K(-72.4%) |
| Dec 2023 | $1.11 M(+542.2%) | $1.11 M(+26.8%) |
| Sep 2023 | - | $876.00 K(+544.1%) |
| Jun 2023 | - | $136.00 K(-46.0%) |
| Mar 2023 | - | $252.00 K(+45.7%) |
| Dec 2022 | $173.00 K(-59.7%) | $173.00 K(-72.7%) |
| Sep 2022 | - | $633.00 K(+224.6%) |
| Jun 2022 | - | $195.00 K(+1.0%) |
| Mar 2022 | - | $193.00 K(-55.0%) |
| Dec 2021 | $429.00 K(-90.7%) | $429.00 K(-72.7%) |
| Sep 2021 | - | $1.57 M(-64.7%) |
| Jun 2021 | - | $4.46 M(-7.0%) |
| Mar 2021 | - | $4.80 M(+4.1%) |
| Dec 2020 | $4.61 M(+351.4%) | $4.61 M(+20.8%) |
| Sep 2020 | - | $3.82 M(+222.9%) |
| Jun 2020 | - | $1.18 M(-40.7%) |
| Mar 2020 | - | $1.99 M(+95.3%) |
| Dec 2019 | $1.02 M(-70.5%) | $1.02 M(+0.9%) |
| Sep 2019 | - | $1.01 M(-61.5%) |
| Jun 2019 | - | $2.63 M(-9.5%) |
| Mar 2019 | - | $2.91 M(-16.1%) |
| Dec 2018 | $3.46 M(-9.0%) | $3.46 M(+35.9%) |
| Sep 2018 | - | $2.55 M(-10.8%) |
| Jun 2018 | - | $2.85 M(-24.0%) |
| Mar 2018 | - | $3.75 M(-1.3%) |
| Dec 2017 | $3.81 M(+893.8%) | $3.81 M(+31.1%) |
| Sep 2017 | - | $2.90 M(-18.7%) |
| Jun 2017 | - | $3.57 M(+1376.5%) |
| Mar 2017 | - | $241.90 K(-36.8%) |
| Dec 2016 | $383.00 K(-25.2%) | $383.00 K(-42.5%) |
| Sep 2016 | - | $665.70 K(-35.0%) |
| Jun 2016 | - | $1.02 M(+501.5%) |
| Mar 2016 | - | $170.30 K(-66.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $512.00 K(+362.5%) | $512.00 K(>+9900.0%) |
| Sep 2015 | - | $0.00(-100.0%) |
| Jun 2015 | - | $387.60 K(-93.5%) |
| Mar 2015 | - | $5.97 M(+5296.6%) |
| Dec 2014 | $110.70 K(-92.2%) | $110.70 K(>+9900.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(-100.0%) |
| Dec 2013 | $1.43 M(-41.3%) | $1.43 M(>+9900.0%) |
| Sep 2013 | - | $0.00(-100.0%) |
| Jun 2013 | - | $1.54 M(-17.5%) |
| Mar 2013 | - | $1.87 M(-23.3%) |
| Dec 2012 | $2.43 M(-45.0%) | $2.43 M(+51.5%) |
| Sep 2012 | - | $1.61 M(-53.4%) |
| Jun 2012 | - | $3.44 M(+200.5%) |
| Mar 2012 | - | $1.15 M(-74.1%) |
| Dec 2011 | $4.42 M(-17.6%) | $4.42 M(+9.5%) |
| Sep 2011 | - | $4.04 M(-7.7%) |
| Jun 2011 | - | $4.38 M(+113.5%) |
| Mar 2011 | - | $2.05 M(-61.8%) |
| Dec 2010 | $5.37 M(-39.5%) | $5.37 M(+12.7%) |
| Sep 2010 | - | $4.76 M(-44.8%) |
| Jun 2010 | - | $8.63 M(-6.2%) |
| Mar 2010 | - | $9.20 M(+3.8%) |
| Dec 2009 | $8.87 M(+133.3%) | $8.87 M(+75.4%) |
| Sep 2009 | - | $5.06 M(+107.3%) |
| Jun 2009 | - | $2.44 M(-75.5%) |
| Mar 2009 | - | $9.96 M(+162.1%) |
| Dec 2008 | $3.80 M(-27.5%) | $3.80 M(-65.2%) |
| Sep 2008 | - | $10.91 M(+33.7%) |
| Jun 2008 | - | $8.16 M(+24.4%) |
| Mar 2008 | - | $6.56 M(+25.1%) |
| Dec 2007 | $5.25 M(+260.4%) | $5.25 M(+63.0%) |
| Sep 2007 | - | $3.22 M(+121.2%) |
| Dec 2006 | $1.46 M | $1.46 M |
FAQ
- What is Altimmune annual accounts receivable?
- What is the all time high annual accounts receivable for Altimmune?
- What is Altimmune annual accounts receivable year-on-year change?
- What is Altimmune quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Altimmune?
- What is Altimmune quarterly accounts receivable year-on-year change?
What is Altimmune annual accounts receivable?
The current annual accounts receivable of ALT is $1.11 M
What is the all time high annual accounts receivable for Altimmune?
Altimmune all-time high annual accounts receivable is $8.87 M
What is Altimmune annual accounts receivable year-on-year change?
Over the past year, ALT annual accounts receivable has changed by +$938.00 K (+542.20%)
What is Altimmune quarterly accounts receivable?
The current quarterly accounts receivable of ALT is $428.00 K
What is the all time high quarterly accounts receivable for Altimmune?
Altimmune all-time high quarterly accounts receivable is $10.91 M
What is Altimmune quarterly accounts receivable year-on-year change?
Over the past year, ALT quarterly accounts receivable has changed by -$683.00 K (-61.48%)